2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE

Star0

DB08358ExperimentalSmall molecule

2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE: Overview.

Mechanism: Pharmacologically active on MAP kinase-activated protein kinase 2
Curator reviewed
Formula / weight: C₂₁H₁₆N₄O · 340.3779 g/mol (avg)

Resolves to

Compound

UNII6GU2ZCN9YNChEMBLCHEMBL226403PubChem10389239

Structure

InChIKeyOWFLADWRSCINST-UHFFFAOYSA-NSMILESO=C1NCCC2=C1C=C(N2)C1=CC(=NC=C1)C1=CC2=C(C=CC=C2)N=C1

Targets

P49137MAPKAPK2Q8IW41MAPKAPK5Q16644MAPKAPK3

What you can answer from here — as of April 02, 2025

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

11+ReferencesStructured and connected to the statements they support

Which drugs share a target with 2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account